Logo image of ESGC

EROS STX GLOBAL CORP (ESGC) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:ESGC - IM00BMT7S123 - Common Stock

3.03
+0.55 (+22.18%)
Last: 6/3/2022, 8:17:40 PM
2.88
-0.15 (-4.95%)
After Hours: 6/3/2022, 8:17:40 PM
Fundamental Rating

1

ESGC gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 80 industry peers in the Entertainment industry. Both the profitability and financial health of ESGC have multiple concerns. While showing a medium growth rate, ESGC is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

ESGC had positive earnings in the past year.
ESGC Yearly Net Income VS EBIT VS OCF VS FCFESGC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 0 200M -200M -400M

1.2 Ratios

Industry RankSector Rank
ROA -37.44%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ESGC Yearly ROA, ROE, ROICESGC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 0 -50 -100 -150

1.3 Margins

Industry RankSector Rank
OM -45.47%
PM (TTM) -269.45%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ESGC Yearly Profit, Operating, Gross MarginsESGC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 0 -100 -200

More info and screens

0

2. Health

2.1 Basic Checks

The number of shares outstanding for ESGC has been increased compared to 1 year ago.
The debt/assets ratio for ESGC is higher compared to a year ago.
ESGC Yearly Shares OutstandingESGC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 50M 100M
ESGC Yearly Total Debt VS Total AssetsESGC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 500M 1B

2.2 Solvency

Based on the Altman-Z score of -2.49, we must say that ESGC is in the distress zone and has some risk of bankruptcy.
A Debt/Equity ratio of 0.71 indicates that ESGC is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.71
Debt/FCF N/A
Altman-Z -2.49
ROIC/WACCN/A
WACCN/A
ESGC Yearly LT Debt VS Equity VS FCFESGC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 0 200M 400M 600M 800M

2.3 Liquidity

ESGC has a Current Ratio of 0.52. This is a bad value and indicates that ESGC is not financially healthy enough and could expect problems in meeting its short term obligations.
ESGC has a Quick Ratio of 0.52. This is a bad value and indicates that ESGC is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.52
Quick Ratio 0.52
ESGC Yearly Current Assets VS Current LiabilitesESGC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 100M 200M 300M

More info and screens

5

3. Growth

3.1 Past

ESGC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 185.97%, which is quite impressive.
ESGC shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 32.11% yearly.
The Revenue for ESGC has decreased by -42.43% in the past year. This is quite bad
ESGC shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -11.36% yearly.
EPS 1Y (TTM)185.97%
EPS 3Y234.3%
EPS 5Y32.11%
EPS Q2Q%-992.43%
Revenue 1Y (TTM)-42.43%
Revenue growth 3Y-14.98%
Revenue growth 5Y-11.36%
Sales Q2Q%344.88%

3.2 Future

The Earnings Per Share is expected to decrease by -34.09% on average over the next years. This is quite bad
The Revenue is expected to grow by 69.34% on average over the next years. This is a very strong growth
EPS Next Y-263.82%
EPS Next 2Y-102.23%
EPS Next 3Y-67.73%
EPS Next 5Y-34.09%
Revenue Next Year86.47%
Revenue Next 2Y52.66%
Revenue Next 3Y43.75%
Revenue Next 5Y69.34%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ESGC Yearly Revenue VS EstimatesESGC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B
ESGC Yearly EPS VS EstimatesESGC Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 -5 10

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

ESGC is valuated cheaply with a Price/Earnings ratio of 1.53.
Compared to an average S&P500 Price/Earnings ratio of 27.19, ESGC is valued rather cheaply.
The Forward Price/Earnings Ratio is negative for ESGC. No positive earnings are expected for the next year.
Industry RankSector Rank
PE 1.53
Fwd PE N/A
ESGC Price Earnings VS Forward Price EarningsESGC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -133.2
ESGC Per share dataESGC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

A cheap valuation may be justified as ESGC's earnings are expected to decrease with -67.73% in the coming years.
PEG (NY)N/A
PEG (5Y)0.05
EPS Next 2Y-102.23%
EPS Next 3Y-67.73%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ESGC!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

EROS STX GLOBAL CORP

NYSE:ESGC (6/3/2022, 8:17:40 PM)

After market: 2.88 -0.15 (-4.95%)

3.03

+0.55 (+22.18%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)01-14 2022-01-14/bmo
Earnings (Next)06-17 2022-06-17/bmo
Inst Owners59.96%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap57.42M
Revenue(TTM)155.50M
Net Income(TTM)-419.00M
Analysts82.86
Price Target3.57 (17.82%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 1.53
Fwd PE N/A
P/S 0.37
P/FCF N/A
P/OCF N/A
P/B 0.14
P/tB N/A
EV/EBITDA -133.2
EPS(TTM)1.98
EY65.35%
EPS(NY)-4.14
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS8.21
BVpS21.24
TBVpSN/A
PEG (NY)N/A
PEG (5Y)0.05
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -37.44%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -45.47%
PM (TTM) -269.45%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.14
Health
Industry RankSector Rank
Debt/Equity 0.71
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.52
Quick Ratio 0.52
Altman-Z -2.49
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)185.97%
EPS 3Y234.3%
EPS 5Y32.11%
EPS Q2Q%-992.43%
EPS Next Y-263.82%
EPS Next 2Y-102.23%
EPS Next 3Y-67.73%
EPS Next 5Y-34.09%
Revenue 1Y (TTM)-42.43%
Revenue growth 3Y-14.98%
Revenue growth 5Y-11.36%
Sales Q2Q%344.88%
Revenue Next Year86.47%
Revenue Next 2Y52.66%
Revenue Next 3Y43.75%
Revenue Next 5Y69.34%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

EROS STX GLOBAL CORP / ESGC FAQ

Can you provide the ChartMill fundamental rating for EROS STX GLOBAL CORP?

ChartMill assigns a fundamental rating of 3 / 10 to ESGC.


What is the valuation status of EROS STX GLOBAL CORP (ESGC) stock?

ChartMill assigns a valuation rating of 9 / 10 to EROS STX GLOBAL CORP (ESGC). This can be considered as Undervalued.


What is the profitability of ESGC stock?

EROS STX GLOBAL CORP (ESGC) has a profitability rating of 1 / 10.


Can you provide the financial health for ESGC stock?

The financial health rating of EROS STX GLOBAL CORP (ESGC) is 0 / 10.